A Systematic Review on Marine Algae-Derived Fucoxanthin: An Update of Pharmacological Insights

Fucoxanthin, belonging to the xanthophyll class of carotenoids, is a natural antioxidant pigment of marine algae, including brown macroalgae and diatoms. It represents 10% of the total carotenoids in nature. The plethora of scientific evidence supports the potential benefits of nutraceutical and pha...

Full description

Saved in:
Bibliographic Details
Published inMarine drugs Vol. 20; no. 5; p. 279
Main Authors Mohibbullah, Md, Haque, Md. Nazmul, Sohag, Abdullah Al Mamun, Hossain, Md. Tahmeed, Zahan, Md. Sarwar, Uddin, Md. Jamal, Hannan, Md. Abdul, Moon, Il Soo, Choi, Jae-Suk
Format Journal Article
LanguageEnglish
Published Switzerland MDPI AG 22.04.2022
MDPI
Subjects
Online AccessGet full text
ISSN1660-3397
1660-3397
DOI10.3390/md20050279

Cover

Loading…
Abstract Fucoxanthin, belonging to the xanthophyll class of carotenoids, is a natural antioxidant pigment of marine algae, including brown macroalgae and diatoms. It represents 10% of the total carotenoids in nature. The plethora of scientific evidence supports the potential benefits of nutraceutical and pharmaceutical uses of fucoxanthin for boosting human health and disease management. Due to its unique chemical structure and action as a single compound with multi-targets of health effects, it has attracted mounting attention from the scientific community, resulting in an escalated number of scientific publications from January 2017 to February 2022. Fucoxanthin has remained the most popular option for anti-cancer and anti-tumor activity, followed by protection against inflammatory, oxidative stress-related, nervous system, obesity, hepatic, diabetic, kidney, cardiac, skin, respiratory and microbial diseases, in a variety of model systems. Despite much pharmacological evidence from in vitro and in vivo findings, fucoxanthin in clinical research is still not satisfactory, because only one clinical study on obesity management was reported in the last five years. Additionally, pharmacokinetics, safety, toxicity, functional stability, and clinical perspective of fucoxanthin are substantially addressed. Nevertheless, fucoxanthin and its derivatives are shown to be safe, non-toxic, and readily available upon administration. This review will provide pharmacological insights into fucoxanthin, underlying the diverse molecular mechanisms of health benefits. However, it requires more activity-oriented translational research in humans before it can be used as a multi-target drug.
AbstractList Fucoxanthin, belonging to the xanthophyll class of carotenoids, is a natural antioxidant pigment of marine algae, including brown macroalgae and diatoms. It represents 10% of the total carotenoids in nature. The plethora of scientific evidence supports the potential benefits of nutraceutical and pharmaceutical uses of fucoxanthin for boosting human health and disease management. Due to its unique chemical structure and action as a single compound with multi-targets of health effects, it has attracted mounting attention from the scientific community, resulting in an escalated number of scientific publications from January 2017 to February 2022. Fucoxanthin has remained the most popular option for anti-cancer and anti-tumor activity, followed by protection against inflammatory, oxidative stress-related, nervous system, obesity, hepatic, diabetic, kidney, cardiac, skin, respiratory and microbial diseases, in a variety of model systems. Despite much pharmacological evidence from in vitro and in vivo findings, fucoxanthin in clinical research is still not satisfactory, because only one clinical study on obesity management was reported in the last five years. Additionally, pharmacokinetics, safety, toxicity, functional stability, and clinical perspective of fucoxanthin are substantially addressed. Nevertheless, fucoxanthin and its derivatives are shown to be safe, non-toxic, and readily available upon administration. This review will provide pharmacological insights into fucoxanthin, underlying the diverse molecular mechanisms of health benefits. However, it requires more activity-oriented translational research in humans before it can be used as a multi-target drug.
Fucoxanthin, belonging to the xanthophyll class of carotenoids, is a natural antioxidant pigment of marine algae, including brown macroalgae and diatoms. It represents 10% of the total carotenoids in nature. The plethora of scientific evidence supports the potential benefits of nutraceutical and pharmaceutical uses of fucoxanthin for boosting human health and disease management. Due to its unique chemical structure and action as a single compound with multi-targets of health effects, it has attracted mounting attention from the scientific community, resulting in an escalated number of scientific publications from January 2017 to February 2022. Fucoxanthin has remained the most popular option for anti-cancer and anti-tumor activity, followed by protection against inflammatory, oxidative stress-related, nervous system, obesity, hepatic, diabetic, kidney, cardiac, skin, respiratory and microbial diseases, in a variety of model systems. Despite much pharmacological evidence from in vitro and in vivo findings, fucoxanthin in clinical research is still not satisfactory, because only one clinical study on obesity management was reported in the last five years. Additionally, pharmacokinetics, safety, toxicity, functional stability, and clinical perspective of fucoxanthin are substantially addressed. Nevertheless, fucoxanthin and its derivatives are shown to be safe, non-toxic, and readily available upon administration. This review will provide pharmacological insights into fucoxanthin, underlying the diverse molecular mechanisms of health benefits. However, it requires more activity-oriented translational research in humans before it can be used as a multi-target drug.Fucoxanthin, belonging to the xanthophyll class of carotenoids, is a natural antioxidant pigment of marine algae, including brown macroalgae and diatoms. It represents 10% of the total carotenoids in nature. The plethora of scientific evidence supports the potential benefits of nutraceutical and pharmaceutical uses of fucoxanthin for boosting human health and disease management. Due to its unique chemical structure and action as a single compound with multi-targets of health effects, it has attracted mounting attention from the scientific community, resulting in an escalated number of scientific publications from January 2017 to February 2022. Fucoxanthin has remained the most popular option for anti-cancer and anti-tumor activity, followed by protection against inflammatory, oxidative stress-related, nervous system, obesity, hepatic, diabetic, kidney, cardiac, skin, respiratory and microbial diseases, in a variety of model systems. Despite much pharmacological evidence from in vitro and in vivo findings, fucoxanthin in clinical research is still not satisfactory, because only one clinical study on obesity management was reported in the last five years. Additionally, pharmacokinetics, safety, toxicity, functional stability, and clinical perspective of fucoxanthin are substantially addressed. Nevertheless, fucoxanthin and its derivatives are shown to be safe, non-toxic, and readily available upon administration. This review will provide pharmacological insights into fucoxanthin, underlying the diverse molecular mechanisms of health benefits. However, it requires more activity-oriented translational research in humans before it can be used as a multi-target drug.
Author Mohibbullah, Md
Uddin, Md. Jamal
Choi, Jae-Suk
Hossain, Md. Tahmeed
Hannan, Md. Abdul
Zahan, Md. Sarwar
Moon, Il Soo
Haque, Md. Nazmul
Sohag, Abdullah Al Mamun
AuthorAffiliation 2 Seafood Research Center, Silla University, #605, Advanced Seafood Processing Complex, Wonyang-ro, Amnam-dong, Seo-gu, Busan 49277, Korea
1 Department of Fishing and Post Harvest Technology, Sher-e-Bangla Agricultural University, Sher-e-Bangla Nagar, Dhaka 1207, Bangladesh; mmohib.fpht@sau.edu.bd
5 Department of Fisheries Biology and Genetics, Patuakhali Science and Technology University, Patuakhali 8602, Bangladesh
7 ABEx Bio-Research Center, East Azampur, Dhaka 1230, Bangladesh; mszahan@hotmail.com (M.S.Z.); hasan800920@gmail.com (M.J.U.)
4 Department of Anatomy, College of Medicine, Dongguk University, Gyeongju 38066, Korea; habib.332@gmail.com (M.N.H.); moonis@dongguk.ac.kr (I.S.M.)
6 Department of Biochemistry and Molecular Biology, Bangladesh Agricultural University, Mymensingh 2202, Bangladesh; sohag2010bmb.sust@gmail.com (A.A.M.S.); tahmeed.hossain@bau.edu.bd (M.T.H.); hannanbmb@bau.edu.bd (M.A.H.)
3 Department of Food Biotechnology, Division of Bioindustry, College of Medical and L
AuthorAffiliation_xml – name: 7 ABEx Bio-Research Center, East Azampur, Dhaka 1230, Bangladesh; mszahan@hotmail.com (M.S.Z.); hasan800920@gmail.com (M.J.U.)
– name: 4 Department of Anatomy, College of Medicine, Dongguk University, Gyeongju 38066, Korea; habib.332@gmail.com (M.N.H.); moonis@dongguk.ac.kr (I.S.M.)
– name: 5 Department of Fisheries Biology and Genetics, Patuakhali Science and Technology University, Patuakhali 8602, Bangladesh
– name: 3 Department of Food Biotechnology, Division of Bioindustry, College of Medical and Life Sciences, Silla University, Busan 46958, Korea
– name: 1 Department of Fishing and Post Harvest Technology, Sher-e-Bangla Agricultural University, Sher-e-Bangla Nagar, Dhaka 1207, Bangladesh; mmohib.fpht@sau.edu.bd
– name: 6 Department of Biochemistry and Molecular Biology, Bangladesh Agricultural University, Mymensingh 2202, Bangladesh; sohag2010bmb.sust@gmail.com (A.A.M.S.); tahmeed.hossain@bau.edu.bd (M.T.H.); hannanbmb@bau.edu.bd (M.A.H.)
– name: 2 Seafood Research Center, Silla University, #605, Advanced Seafood Processing Complex, Wonyang-ro, Amnam-dong, Seo-gu, Busan 49277, Korea
Author_xml – sequence: 1
  givenname: Md
  orcidid: 0000-0002-7845-5908
  surname: Mohibbullah
  fullname: Mohibbullah, Md
– sequence: 2
  givenname: Md. Nazmul
  surname: Haque
  fullname: Haque, Md. Nazmul
– sequence: 3
  givenname: Abdullah Al Mamun
  orcidid: 0000-0001-9084-2364
  surname: Sohag
  fullname: Sohag, Abdullah Al Mamun
– sequence: 4
  givenname: Md. Tahmeed
  orcidid: 0000-0003-3603-669X
  surname: Hossain
  fullname: Hossain, Md. Tahmeed
– sequence: 5
  givenname: Md. Sarwar
  orcidid: 0000-0001-5768-4317
  surname: Zahan
  fullname: Zahan, Md. Sarwar
– sequence: 6
  givenname: Md. Jamal
  orcidid: 0000-0003-2911-3255
  surname: Uddin
  fullname: Uddin, Md. Jamal
– sequence: 7
  givenname: Md. Abdul
  orcidid: 0000-0001-6640-4495
  surname: Hannan
  fullname: Hannan, Md. Abdul
– sequence: 8
  givenname: Il Soo
  orcidid: 0000-0002-1608-016X
  surname: Moon
  fullname: Moon, Il Soo
– sequence: 9
  givenname: Jae-Suk
  orcidid: 0000-0002-8151-6054
  surname: Choi
  fullname: Choi, Jae-Suk
BackLink https://www.ncbi.nlm.nih.gov/pubmed/35621930$$D View this record in MEDLINE/PubMed
BookMark eNptkk1v1DAQhiNURD_gwg9AlrggpMAkTpwNh0qrQmGlIhDQK9bYnux6ldiLnSz03-NlW2grTrZmnnn1zsdxduC8oyx7WsArzlt4PZgSoIayaR9kR4UQkKdwc3Drf5gdx7gG4PWsrR5lh7wWZdFyOMq-z9nXqzjSgKPV7AttLf1k3rGPGKwjNu-XSPlbCnZLhp1P2v9CN66se8Pmjl1uDI7EfMc-rzAMqH3vl1ZjzxYu2uVqjI-zhx32kZ5cvyfZ5fm7b2cf8otP7xdn84tcV0055qoRM92SoAaNxkq0RUWdJkLFwTStghoVdMIUHGAGXaeUQqy7RlGhUQvgJ9lir2s8ruUm2AHDlfRo5Z-AD0uJIXXYkzTcKN2WGmtjqmoGSgijqWsBoaIau6R1utfaTGqglHNjwP6O6N2Msyu59FuZXIvUSBJ4cS0Q_I-J4igHGzX1PTryU5SlaIqyqeuySOjze-jaT8GlUe0o4GkUlUjUs9uO_lq5WWMCYA_o4GMM1Eltx7RRvzNoe1mA3F2K_HcpqeTlvZIb1f_AvwEVnL_H
CitedBy_id crossref_primary_10_3390_md21060340
crossref_primary_10_3390_nu15020464
crossref_primary_10_3390_md20100592
crossref_primary_10_1016_j_fbio_2024_103774
crossref_primary_10_1016_j_fbio_2024_104421
crossref_primary_10_3390_molecules27196713
crossref_primary_10_1016_j_ijbiomac_2024_130264
crossref_primary_10_1007_s12033_024_01173_y
crossref_primary_10_1021_acs_jafc_4c00590
crossref_primary_10_3390_molecules29010061
crossref_primary_10_1016_j_phanu_2025_100432
crossref_primary_10_3390_md20100618
crossref_primary_10_3390_md22070327
crossref_primary_10_31857_S0134347523030099
crossref_primary_10_3390_ph17070960
crossref_primary_10_3390_life13091831
crossref_primary_10_1017_erm_2023_18
crossref_primary_10_1038_s41598_024_83909_z
crossref_primary_10_3390_macromol5010011
crossref_primary_10_3390_nu15081954
crossref_primary_10_3390_md22020093
crossref_primary_10_1134_S1063074023030094
crossref_primary_10_4103_jmau_jmau_104_24
crossref_primary_10_3390_cells12071053
crossref_primary_10_37349_eaa_2024_00035
crossref_primary_10_1039_D3FO02633G
crossref_primary_10_1016_j_intimp_2023_110370
crossref_primary_10_3390_ijms24065388
crossref_primary_10_3390_md23020066
crossref_primary_10_1016_j_mtsust_2024_100935
crossref_primary_10_3390_app12199452
crossref_primary_10_1016_j_algal_2025_103990
crossref_primary_10_1111_pai_13979
crossref_primary_10_3390_ijms23158301
crossref_primary_10_3390_md21070391
crossref_primary_10_3390_foods12173167
crossref_primary_10_1002_fsn3_3265
crossref_primary_10_37349_ent_2023_00058
crossref_primary_10_1007_s43630_023_00407_3
crossref_primary_10_1016_j_brainresbull_2022_11_018
crossref_primary_10_1016_j_phytol_2024_03_009
crossref_primary_10_1186_s43014_023_00155_y
crossref_primary_10_3390_molecules28073267
crossref_primary_10_1021_acs_jafc_4c03677
crossref_primary_10_1016_j_oor_2024_100552
crossref_primary_10_61186_jambr_32_151_135
crossref_primary_10_1016_j_tifs_2024_104760
crossref_primary_10_1016_j_jff_2022_105359
Cites_doi 10.1016/j.btre.2018.e00296
10.1615/JEnvironPatholToxicolOncol.2019030997
10.1155/2021/6688708
10.3390/molecules26144198
10.3390/antiox9040328
10.1007/s11064-016-2123-6
10.3390/md13106521
10.1080/21655979.2021.1973875
10.2131/jts.34.501
10.3322/caac.21660
10.3390/md17010069
10.1016/j.jksus.2020.01.027
10.4314/tjpr.v19i5.4
10.3390/md19020092
10.3390/md9101806
10.1007/s13577-017-0188-4
10.3390/md19110606
10.1021/acs.jafc.7b00805
10.1021/jf050926w
10.3390/md17120702
10.1017/S0007114508199007
10.1039/C9FO01018A
10.1007/s10811-018-1458-6
10.1021/acsomega.9b00871
10.1053/j.ajkd.2011.02.385
10.3390/jcm9010090
10.2174/1381612826666200628022812
10.1021/acs.jafc.6b04376
10.3389/fnmol.2020.00116
10.1016/j.tifs.2021.03.012
10.1002/fsn3.2301
10.3390/jcm11041136
10.1208/s12248-022-00679-0
10.3390/molecules26144288
10.3390/md19030132
10.1038/srep46763
10.1208/s12248-018-0197-6
10.1038/s41598-020-80748-6
10.3390/ijms21062180
10.3390/nu11040796
10.1186/s12906-018-2164-2
10.1007/s12011-020-02291-9
10.1080/16546628.2017.1304678
10.3390/md19060334
10.1177/0300060520964011
10.1158/1940-6207.CAPR-08-0193
10.3390/md17050304
10.3390/md19060307
10.3390/biomedicines9060620
10.1016/j.neuint.2019.01.010
10.3390/ijms20184485
10.3390/antiox9121176
10.2174/1567205018666211118144602
10.3390/md17030152
10.3390/nu13041079
10.1146/annurev.immunol.24.021605.090646
10.1007/s11802-019-4019-y
10.1038/ki.2013.153
10.1016/j.jep.2020.113302
10.3390/md16090323
10.3390/antiox10071092
10.1615/JEnvironPatholToxicolOncol.2019030301
10.1016/j.jnutbio.2021.108871
10.1021/acs.jafc.1c00569
10.3389/fphar.2019.00906
10.3390/md17050311
10.1155/2017/6792543
10.1021/acs.chemrestox.0c00235
10.1007/s00394-021-02509-z
10.3390/pharmaceutics12020136
10.1016/j.biopha.2018.07.088
10.3390/md17100552
10.3164/jcbn.16-112
10.1002/ddr.21451
10.1089/ham.2015.0109
10.3136/nskkk.55.304
10.1016/j.bbrc.2020.05.050
10.1039/D0FO00442A
10.1016/j.jff.2018.07.048
10.1002/aocs.12092
10.1016/j.bbrc.2017.11.022
10.3390/md18110557
10.21873/anticanres.14703
10.20944/preprints202005.0342.v1
10.1615/JEnvironPatholToxicolOncol.2019030154
10.1016/j.toxrep.2021.02.005
10.3390/antiox8080239
10.3390/md16100378
10.1016/j.algal.2021.102187
10.3390/antiox8060183
10.1016/j.jhep.2018.09.014
10.1080/14786419.2018.1528593
10.31989/ffhd.v7i4.333
10.1016/j.ejphar.2021.174629
10.1016/j.jff.2017.07.009
10.1021/acs.jafc.0c01467
10.1016/j.etap.2018.02.006
10.1007/s11011-018-0368-2
10.3390/foods9081113
10.1111/jcmm.14151
10.1016/j.jff.2019.103542
10.1002/mnfr.202000405
10.3390/ijms222413620
10.3390/cells10061311
10.21873/anticanres.14887
ContentType Journal Article
Copyright 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2022 by the authors. 2022
Copyright_xml – notice: 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2022 by the authors. 2022
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7T7
7TN
7X7
7XB
88E
8FD
8FE
8FH
8FI
8FJ
8FK
ABUWG
AEUYN
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
BKSAR
C1K
CCPQU
DWQXO
F1W
FR3
FYUFA
GHDGH
GNUQQ
H95
H99
HCIFZ
K9.
L.F
L.G
LK8
M0S
M1P
M7P
P64
PCBAR
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.3390/md20050279
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Industrial and Applied Microbiology Abstracts (Microbiology A)
Oceanic Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Technology Research Database
ProQuest SciTech Collection
ProQuest Natural Science Collection
ProQuest Hospital Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest One Sustainability
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
ProQuest Natural Science Collection
Earth, Atmospheric & Aquatic Science Collection
Environmental Sciences and Pollution Management
ProQuest One Community College
ProQuest Central Korea
ASFA: Aquatic Sciences and Fisheries Abstracts
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
Aquatic Science & Fisheries Abstracts (ASFA) 1: Biological Sciences & Living Resources
ASFA: Marine Biotechnology Abstracts
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Aquatic Science & Fisheries Abstracts (ASFA) Marine Biotechnology Abstracts
Aquatic Science & Fisheries Abstracts (ASFA) Professional
Biological Sciences
ProQuest Health & Medical Collection
Medical Database
ProQuest Biological Science Database (NC LIVE)
Biotechnology and BioEngineering Abstracts
ProQuest Earth, Atmospheric & Aquatic Science Database (NC LIVE)
ProQuest Central Premium
ProQuest One Academic
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
Aquatic Science & Fisheries Abstracts (ASFA) Professional
ProQuest Central Student
Technology Research Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Central China
Environmental Sciences and Pollution Management
ProQuest Central
Earth, Atmospheric & Aquatic Science Collection
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Oceanic Abstracts
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Health & Medical Research Collection
Biological Science Collection
Aquatic Science & Fisheries Abstracts (ASFA) Marine Biotechnology Abstracts
Aquatic Science & Fisheries Abstracts (ASFA) 1: Biological Sciences & Living Resources
Industrial and Applied Microbiology Abstracts (Microbiology A)
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
Earth, Atmospheric & Aquatic Science Database
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ASFA: Aquatic Sciences and Fisheries Abstracts
Engineering Research Database
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
Publicly Available Content Database

MEDLINE
CrossRef
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1660-3397
ExternalDocumentID oai_doaj_org_article_d3dbc92ca5dd4480b66dcef90a04e5af
PMC9146768
35621930
10_3390_md20050279
Genre Systematic Review
Journal Article
GrantInformation_xml – fundername: This research was funded by the National Research Foundation of Korea (NRF) through Brain Pool Program
  grantid: Grant No. 2021H1D3A2A01100053
GroupedDBID ---
29M
2WC
53G
5GY
5VS
7X7
88E
8CJ
8FE
8FH
8FI
8FJ
AADQD
AAHBH
AAYXX
ABUWG
ACGFO
ACIHN
ACPRK
ADBBV
AEAQA
AENEX
AEUYN
AFKRA
AFRAH
AFZYC
AHMBA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BBNVY
BCNDV
BENPR
BHPHI
BKSAR
BPHCQ
BVXVI
CCPQU
CITATION
CS3
D1J
DIK
DU5
E3Z
EBD
EDH
F5P
FYUFA
GROUPED_DOAJ
GX1
HCIFZ
HH5
HMCUK
HYE
IAO
IHR
ITC
KQ8
LK5
LK8
M1P
M48
M7P
M7R
MK0
MODMG
M~E
O5R
O5S
OK1
OVT
P2P
PCBAR
PGMZT
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
RNS
RPM
TR2
UKHRP
XSB
CGR
CUY
CVF
ECM
EIF
NPM
PJZUB
PPXIY
PQGLB
3V.
7T7
7TN
7XB
8FD
8FK
AZQEC
C1K
DWQXO
F1W
FR3
GNUQQ
H95
H99
K9.
L.F
L.G
P64
PKEHL
PQEST
PQUKI
PRINS
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c472t-b768c9e6e7adca46914efceeab30d79b05ab0f6d130080ffbbbaa5f7be1cac603
IEDL.DBID M48
ISSN 1660-3397
IngestDate Wed Aug 27 01:24:13 EDT 2025
Thu Aug 21 18:00:11 EDT 2025
Thu Jul 10 18:28:30 EDT 2025
Fri Jul 25 10:40:21 EDT 2025
Mon Jul 21 06:05:16 EDT 2025
Tue Jul 01 03:19:50 EDT 2025
Thu Apr 24 23:14:53 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 5
Keywords pharmacokinetics
safety and toxicity
in vivo
fucoxanthin
in vitro
bioactivities
Language English
License https://creativecommons.org/licenses/by/4.0
Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c472t-b768c9e6e7adca46914efceeab30d79b05ab0f6d130080ffbbbaa5f7be1cac603
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
content type line 14
ObjectType-Feature-3
ObjectType-Evidence Based Healthcare-1
ObjectType-Article-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
ObjectType-Undefined-4
ORCID 0000-0002-7845-5908
0000-0003-3603-669X
0000-0003-2911-3255
0000-0002-8151-6054
0000-0002-1608-016X
0000-0001-6640-4495
0000-0001-9084-2364
0000-0001-5768-4317
OpenAccessLink https://doaj.org/article/d3dbc92ca5dd4480b66dcef90a04e5af
PMID 35621930
PQID 2670346946
PQPubID 2032365
ParticipantIDs doaj_primary_oai_doaj_org_article_d3dbc92ca5dd4480b66dcef90a04e5af
pubmedcentral_primary_oai_pubmedcentral_nih_gov_9146768
proquest_miscellaneous_2671275521
proquest_journals_2670346946
pubmed_primary_35621930
crossref_citationtrail_10_3390_md20050279
crossref_primary_10_3390_md20050279
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20220422
PublicationDateYYYYMMDD 2022-04-22
PublicationDate_xml – month: 4
  year: 2022
  text: 20220422
  day: 22
PublicationDecade 2020
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
– name: Basel
PublicationTitle Marine drugs
PublicationTitleAlternate Mar Drugs
PublicationYear 2022
Publisher MDPI AG
MDPI
Publisher_xml – name: MDPI AG
– name: MDPI
References ref_94
Kim (ref_35) 2021; 60
Carpena (ref_5) 2021; 117
ref_14
Ye (ref_56) 2020; 48
Wang (ref_80) 2020; 32
ref_98
Li (ref_36) 2020; 11
Sung (ref_47) 2021; 71
Hashimoto (ref_105) 2009; 102
Beppu (ref_107) 2009; 34
Lin (ref_84) 2017; 2017
Terasaki (ref_48) 2017; 61
Yang (ref_8) 2021; 12
ref_25
Dai (ref_40) 2021; 8
ref_24
ref_23
ref_21
Miyashita (ref_109) 2017; 36
Yu (ref_85) 2017; 61
Sharma (ref_63) 2021; 54
Li (ref_6) 2021; 6
Xiang (ref_18) 2017; 65
Willmann (ref_81) 2015; 16
Wu (ref_89) 2021; 2021
ref_72
ref_71
ref_70
Lopes (ref_52) 2020; 40
ref_79
Hitoe (ref_15) 2017; 7
Huang (ref_65) 2021; 46
Liu (ref_99) 2019; 18
ref_75
Chang (ref_16) 2018; 495
Surendraraj (ref_30) 2018; 95
Hosseinzade (ref_31) 2020; 19
Sun (ref_17) 2020; 68
ref_83
Yu (ref_53) 2018; 31
Li (ref_95) 2019; 38
Ma (ref_112) 2019; 4
Ming (ref_60) 2021; 265
Zhao (ref_11) 2017; 42
Terasaki (ref_49) 2021; 41
Dash (ref_82) 2021; 27
Takatani (ref_37) 2020; 528
Kadekaru (ref_108) 2008; 55
Wang (ref_12) 2019; 23
Kinsey (ref_77) 2011; 58
Yang (ref_88) 2021; 69
ref_57
Duncan (ref_96) 2009; 2
Yang (ref_10) 2020; 34
Lewington (ref_78) 2013; 84
Dhami (ref_87) 2021; 18
ref_59
Jiang (ref_41) 2019; 34
Hudlikar (ref_20) 2021; 34
Zhang (ref_91) 2017; 7
Hannan (ref_29) 2020; 13
ref_61
Foo (ref_55) 2019; 21
ref_69
Su (ref_44) 2019; 10
Ghasempour (ref_51) 2018; 4
ref_62
Jin (ref_76) 2019; 80
Almeida (ref_13) 2018; 59
Kuntiya (ref_28) 2013; 8
Guo (ref_64) 2019; 10
Wang (ref_73) 2020; 16
Koo (ref_111) 2016; 64
Strait (ref_93) 2008; 21
Chai (ref_100) 2020; 19
Mohibbullah (ref_19) 2018; 30
Aman (ref_2) 2005; 53
ref_34
ref_33
ref_110
ref_113
Zhang (ref_66) 2018; 48
Hu (ref_90) 2018; 106
Lee (ref_45) 2021; 11
ref_39
ref_38
Yang (ref_67) 2021; 913
Adamczak (ref_26) 2019; 8
Guo (ref_22) 2020; 16
ref_103
ref_106
Chen (ref_54) 2019; 38
Takatani (ref_46) 2021; 65
Wang (ref_58) 2022; 24
ref_43
Alghazwi (ref_86) 2019; 124
Yang (ref_32) 2019; 38
ref_42
ref_102
ref_1
ref_3
Terasaki (ref_50) 2022; 99
Walsh (ref_92) 2006; 24
ref_9
Peng (ref_27) 2011; 9
Yang (ref_97) 2018; 20
ref_4
ref_7
Oliyaei (ref_68) 2021; 9
Asrani (ref_74) 2019; 70
Yang (ref_101) 2021; 199
Zhang (ref_104) 2015; 13
References_xml – volume: 21
  start-page: e00296
  year: 2019
  ident: ref_55
  article-title: Increased fucoxanthin in Chaetoceros calcitrans extract exacerbates apoptosis in liver cancer cells via multiple targeted cellular pathways
  publication-title: Biotechnol. Rep.
  doi: 10.1016/j.btre.2018.e00296
– volume: 38
  start-page: 365
  year: 2019
  ident: ref_95
  article-title: Restorative Effect of Fucoxanthin in an Ovalbumin-Induced Allergic Rhinitis Animal Model through NF-kappaB p65 and STAT3 Signaling
  publication-title: J. Environ. Pathol. Toxicol. Oncol.
  doi: 10.1615/JEnvironPatholToxicolOncol.2019030997
– volume: 46
  start-page: 171
  year: 2021
  ident: ref_65
  article-title: Effect of fucoxanthin on insulin resistance in obese mice induced by high fat diet
  publication-title: Zhongguo Zhongyao Zazhi
– volume: 2021
  start-page: 6688708
  year: 2021
  ident: ref_89
  article-title: Fucoxanthin Prevents 6-OHDA-Induced Neurotoxicity by Targeting Keap1
  publication-title: Oxid. Med. Cell. Longev.
  doi: 10.1155/2021/6688708
– ident: ref_4
  doi: 10.3390/molecules26144198
– ident: ref_34
  doi: 10.3390/antiox9040328
– volume: 42
  start-page: 667
  year: 2017
  ident: ref_11
  article-title: Anti-Neuroinflammatory Effects of Fucoxanthin via Inhibition of Akt/NF-κB and MAPKs/AP-1 Pathways and Activation of PKA/CREB Pathway in Lipopolysaccharide-Activated BV-2 Microglial Cells
  publication-title: Neurochem. Res.
  doi: 10.1007/s11064-016-2123-6
– volume: 13
  start-page: 6521
  year: 2015
  ident: ref_104
  article-title: Simultaneous Determination of Fucoxanthin and Its Deacetylated Metabolite Fucoxanthinol in Rat Plasma by Liquid Chromatography-Tandem Mass Spectrometry
  publication-title: Mar. Drugs
  doi: 10.3390/md13106521
– volume: 12
  start-page: 7235
  year: 2021
  ident: ref_8
  article-title: Role of Fucoxanthin towards Cadmium-induced renal impairment with the antioxidant and anti-lipid peroxide activities
  publication-title: Bioengineered
  doi: 10.1080/21655979.2021.1973875
– volume: 34
  start-page: 501
  year: 2009
  ident: ref_107
  article-title: Single and repeated oral dose toxicity study of fucoxanthin (FX), a marine carotenoid, in mice
  publication-title: J. Toxicol. Sci.
  doi: 10.2131/jts.34.501
– volume: 71
  start-page: 209
  year: 2021
  ident: ref_47
  article-title: Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
  publication-title: CA Cancer J. Clin.
  doi: 10.3322/caac.21660
– ident: ref_72
  doi: 10.3390/md17010069
– volume: 32
  start-page: 1896
  year: 2020
  ident: ref_80
  article-title: Antiurolithiatic effect of Fucoxanthin on ethylene glycol-induced renal calculus in experimental rats
  publication-title: J. King Saud Univ.-Sci.
  doi: 10.1016/j.jksus.2020.01.027
– volume: 19
  start-page: 933
  year: 2020
  ident: ref_100
  article-title: Fucoxanthin improves functional recovery of orbitopathy in Graves’ disease by downregulating IL-17 mRNA expression in a mouse model
  publication-title: Trop. J. Pharm. Res.
  doi: 10.4314/tjpr.v19i5.4
– ident: ref_113
  doi: 10.3390/md19020092
– volume: 9
  start-page: 1806
  year: 2011
  ident: ref_27
  article-title: Fucoxanthin, a marine carotenoid present in brown seaweeds and diatoms: Metabolism and bioactivities relevant to human health
  publication-title: Mar. Drugs
  doi: 10.3390/md9101806
– volume: 31
  start-page: 50
  year: 2018
  ident: ref_53
  article-title: Inhibition of two gastric cancer cell lines induced by fucoxanthin involves downregulation of Mcl-1 and STAT3
  publication-title: Hum. Cell
  doi: 10.1007/s13577-017-0188-4
– volume: 21
  start-page: 521
  year: 2008
  ident: ref_93
  article-title: Suppression of NF-κB activation blocks osteoclastic bone resorption during estrogen deficiency
  publication-title: Int. J. Mol. Med.
– ident: ref_1
  doi: 10.3390/md19110606
– volume: 65
  start-page: 4092
  year: 2017
  ident: ref_18
  article-title: Fucoxanthin Inhibits β-Amyloid Assembly and Attenuates β-Amyloid Oligomer-Induced Cognitive Impairments
  publication-title: J. Agric. Food Chem.
  doi: 10.1021/acs.jafc.7b00805
– volume: 53
  start-page: 9512
  year: 2005
  ident: ref_2
  article-title: Effects of heating and illumination on trans-cis isomerization and degradation of beta-carotene and lutein in isolated spinach chloroplasts
  publication-title: J. Agric. Food Chem.
  doi: 10.1021/jf050926w
– ident: ref_79
  doi: 10.3390/md17120702
– volume: 102
  start-page: 242
  year: 2009
  ident: ref_105
  article-title: The distribution and accumulation of fucoxanthin and its metabolites after oral administration in mice
  publication-title: Br. J. Nutr.
  doi: 10.1017/S0007114508199007
– volume: 10
  start-page: 5644
  year: 2019
  ident: ref_64
  article-title: Fucoxanthin modulates cecal and fecal microbiota differently based on diet
  publication-title: Food Funct.
  doi: 10.1039/C9FO01018A
– volume: 30
  start-page: 3243
  year: 2018
  ident: ref_19
  article-title: Neuroprotective effects of fucoxanthin and its derivative fucoxanthinol from the phaeophyte Undaria pinnatifida attenuate oxidative stress in hippocampal neurons
  publication-title: J. Appl. Phycol.
  doi: 10.1007/s10811-018-1458-6
– volume: 4
  start-page: 10502
  year: 2019
  ident: ref_112
  article-title: Fucoxanthin-Loaded Oil-in-Water Emulsion-Based Delivery Systems: Effects of Natural Emulsifiers on the Formulation, Stability, and Bioaccessibility
  publication-title: ACS Omega
  doi: 10.1021/acsomega.9b00871
– volume: 58
  start-page: 291
  year: 2011
  ident: ref_77
  article-title: Pathogenesis of acute kidney injury: Foundation for clinical practice
  publication-title: Am. J. Kidney Dis.
  doi: 10.1053/j.ajkd.2011.02.385
– ident: ref_14
  doi: 10.3390/jcm9010090
– volume: 27
  start-page: 383
  year: 2021
  ident: ref_82
  article-title: Phytosterols: Targeting neuroinflammation in neurodegeneration
  publication-title: Curr. Pharm. Des.
  doi: 10.2174/1381612826666200628022812
– volume: 64
  start-page: 9428
  year: 2016
  ident: ref_111
  article-title: Preparation of Fucoxanthin-Loaded Nanoparticles Composed of Casein and Chitosan with Improved Fucoxanthin Bioavailability
  publication-title: J. Agric. Food Chem.
  doi: 10.1021/acs.jafc.6b04376
– volume: 13
  start-page: 116
  year: 2020
  ident: ref_29
  article-title: Neuroprotection Against Oxidative Stress: Phytochemicals Targeting TrkB Signaling and the Nrf2-ARE Antioxidant System
  publication-title: Front. Mol. Neurosci.
  doi: 10.3389/fnmol.2020.00116
– volume: 117
  start-page: 163
  year: 2021
  ident: ref_5
  article-title: Biological action mechanisms of fucoxanthin extracted from algae for application in food and cosmetic industries
  publication-title: Trends Food Sci. Technol.
  doi: 10.1016/j.tifs.2021.03.012
– volume: 9
  start-page: 3521
  year: 2021
  ident: ref_68
  article-title: Antidiabetic effect of fucoxanthin extracted from Sargassum angustifolium on streptozotocin-nicotinamide-induced type 2 diabetic mice
  publication-title: Food Sci. Nutr.
  doi: 10.1002/fsn3.2301
– ident: ref_69
  doi: 10.3390/jcm11041136
– volume: 24
  start-page: 30
  year: 2022
  ident: ref_58
  article-title: Nfe2l2 Regulates Metabolic Rewiring and Epigenetic Reprogramming in Mediating Cancer Protective Effect by Fucoxanthin
  publication-title: AAPS J.
  doi: 10.1208/s12248-022-00679-0
– ident: ref_59
  doi: 10.3390/molecules26144288
– ident: ref_94
  doi: 10.3390/md19030132
– volume: 7
  start-page: srep46763
  year: 2017
  ident: ref_91
  article-title: Fucoxanthin provides neuroprotection in models of traumatic brain injury via the Nrf2-ARE and Nrf2-autophagy pathways
  publication-title: Sci. Rep.
  doi: 10.1038/srep46763
– volume: 20
  start-page: 32
  year: 2018
  ident: ref_97
  article-title: Fucoxanthin Elicits Epigenetic Modifications, Nrf2 Activation and Blocking Transformation in Mouse Skin JB6 P+ Cells
  publication-title: AAPS J.
  doi: 10.1208/s12248-018-0197-6
– volume: 11
  start-page: 543
  year: 2021
  ident: ref_45
  article-title: Fucoxanthin from microalgae Phaeodactylum tricornutum inhibits pro-inflammatory cytokines by regulating both NF-κB and NLRP3 inflammasome activation
  publication-title: Sci. Rep.
  doi: 10.1038/s41598-020-80748-6
– volume: 16
  start-page: 214
  year: 2020
  ident: ref_73
  article-title: Fucoxanthin averts isoprenaline hydrochloride-induced myocardial infarction in rats
  publication-title: Pharmacogn. Mag.
– ident: ref_98
  doi: 10.3390/ijms21062180
– ident: ref_61
  doi: 10.3390/nu11040796
– ident: ref_75
  doi: 10.1186/s12906-018-2164-2
– volume: 199
  start-page: 1877
  year: 2021
  ident: ref_101
  article-title: Effect of Fucoxanthin Administration on Thyroid Gland Injury Induced by Cadmium in Mice
  publication-title: Biol. Trace Elem. Res.
  doi: 10.1007/s12011-020-02291-9
– volume: 61
  start-page: 1304678
  year: 2017
  ident: ref_85
  article-title: Fucoxanthin prevents H2O2-induced neuronal apoptosis via concurrently activating the PI3-K/Akt cascade and inhibiting the ERK pathway
  publication-title: Food Nutr. Res.
  doi: 10.1080/16546628.2017.1304678
– volume: 6
  start-page: 100245
  year: 2021
  ident: ref_6
  article-title: Fucoxanthin metabolites exert anti-fibrogenic and antioxidant effects in hepatic stellate cells
  publication-title: J. Agric. Food Res.
– ident: ref_38
  doi: 10.3390/md19060334
– volume: 48
  start-page: 300060520964011
  year: 2020
  ident: ref_56
  article-title: Fucoxanthin may inhibit cervical cancer cell proliferation via downregulation of HIST1H3D
  publication-title: J. Int. Med. Res.
  doi: 10.1177/0300060520964011
– volume: 2
  start-page: 665
  year: 2009
  ident: ref_96
  article-title: Topical treatment with black raspberry extract reduces cutaneous UVB-induced carcinogenesis and inflammation
  publication-title: Cancer Prev. Res.
  doi: 10.1158/1940-6207.CAPR-08-0193
– ident: ref_103
  doi: 10.3390/md17050304
– ident: ref_70
  doi: 10.3390/md19060307
– ident: ref_71
  doi: 10.3390/biomedicines9060620
– volume: 124
  start-page: 215
  year: 2019
  ident: ref_86
  article-title: In vitro studies of the neuroprotective activities of astaxanthin and fucoxanthin against amyloid beta (Aβ 1-42 ) toxicity and aggregation
  publication-title: Neurochem. Int.
  doi: 10.1016/j.neuint.2019.01.010
– ident: ref_3
  doi: 10.3390/ijms20184485
– ident: ref_23
  doi: 10.3390/antiox9121176
– volume: 18
  start-page: 623
  year: 2021
  ident: ref_87
  article-title: Neuroprotective Effect of Fucoxanthin against Intracerebroventricular Streptozotocin (ICV-STZ) Induced Cognitive Impairment in Experimental Rats
  publication-title: Curr. Alzheimer Res.
  doi: 10.2174/1567205018666211118144602
– ident: ref_42
  doi: 10.3390/md17030152
– ident: ref_102
  doi: 10.3390/nu13041079
– volume: 24
  start-page: 33
  year: 2006
  ident: ref_92
  article-title: Osteoimmunology: Interplay between the immune system and bone metabolism
  publication-title: Annu. Rev. Immunol.
  doi: 10.1146/annurev.immunol.24.021605.090646
– volume: 18
  start-page: 926
  year: 2019
  ident: ref_99
  article-title: Fucoxanthin isolated from Undaria pinnatifida can interact with Escherichia coli and lactobacilli in the intestine and inhibit the growth of pathogenic bacteria
  publication-title: J. Ocean Univ. China
  doi: 10.1007/s11802-019-4019-y
– volume: 84
  start-page: 457
  year: 2013
  ident: ref_78
  article-title: Raising awareness of acute kidney injury: A global perspective of a silent killer
  publication-title: Kidney Int.
  doi: 10.1038/ki.2013.153
– volume: 265
  start-page: 113302
  year: 2021
  ident: ref_60
  article-title: Fucoxanthin extracted from Laminaria Japonica inhibits metastasis and enhances the sensitivity of lung cancer to Gefitinib
  publication-title: J. Ethnopharmacol.
  doi: 10.1016/j.jep.2020.113302
– ident: ref_25
  doi: 10.3390/md16090323
– ident: ref_33
  doi: 10.3390/antiox10071092
– volume: 38
  start-page: 239
  year: 2019
  ident: ref_54
  article-title: Anti-inflammatory and apoptotic signaling effect of fucoxanthin on benzo(A)pyrene-induced lung cancer in mice
  publication-title: J. Environ. Pathol. Toxicol. Oncol.
  doi: 10.1615/JEnvironPatholToxicolOncol.2019030301
– volume: 99
  start-page: 108871
  year: 2022
  ident: ref_50
  article-title: Suppression of C-C chemokine receptor 1 is a key regulation for colon cancer chemoprevention in AOM/DSS mice by fucoxanthin
  publication-title: J. Nutr. Biochem.
  doi: 10.1016/j.jnutbio.2021.108871
– volume: 69
  start-page: 9764
  year: 2021
  ident: ref_88
  article-title: PLGA-PEG Nanoparticles Facilitate in Vivo Anti-Alzheimer’s Effects of Fucoxanthin, a Marine Carotenoid Derived from Edible Brown Algae
  publication-title: J. Agric. Food Chem.
  doi: 10.1021/acs.jafc.1c00569
– volume: 10
  start-page: 906
  year: 2019
  ident: ref_44
  article-title: Fucoxanthin, a marine xanthophyll isolated from Conticribra weissflogii ND-8: Preventive anti-inflammatory effect in a mouse model of sepsis
  publication-title: Front. Pharmacol.
  doi: 10.3389/fphar.2019.00906
– ident: ref_62
  doi: 10.3390/md17050311
– volume: 2017
  start-page: 6792543
  year: 2017
  ident: ref_84
  article-title: Fucoxanthin, a Marine Carotenoid, Attenuates β -Amyloid Oligomer-Induced Neurotoxicity Possibly via Regulating the PI3K/Akt and the ERK Pathways in SH-SY5Y Cells
  publication-title: Oxid. Med. Cell. Longev.
  doi: 10.1155/2017/6792543
– volume: 34
  start-page: 713
  year: 2021
  ident: ref_20
  article-title: Epigenomic, Transcriptomic, and Protective Effect of Carotenoid Fucoxanthin in High Glucose-Induced Oxidative Stress in Mes13 Kidney Mesangial Cells
  publication-title: Chem. Res. Toxicol.
  doi: 10.1021/acs.chemrestox.0c00235
– volume: 60
  start-page: 3315
  year: 2021
  ident: ref_35
  article-title: Fucoxanthin inhibits lipopolysaccharide-induced inflammation and oxidative stress by activating nuclear factor E2-related factor 2 via the phosphatidylinositol 3-kinase/AKT pathway in macrophages
  publication-title: Eur. J. Nutr.
  doi: 10.1007/s00394-021-02509-z
– ident: ref_39
  doi: 10.3390/pharmaceutics12020136
– volume: 106
  start-page: 1484
  year: 2018
  ident: ref_90
  article-title: Neuroprotective role of fucoxanthin against cerebral ischemic/reperfusion injury through activation of Nrf2/HO-1 signaling
  publication-title: Biomed. Pharmacother.
  doi: 10.1016/j.biopha.2018.07.088
– ident: ref_9
  doi: 10.3390/md17100552
– volume: 19
  start-page: 2901
  year: 2020
  ident: ref_31
  article-title: Optimization of production and antioxidant activity of fucoxanthin from marine haptophyte algae, Isochrysis galbana
  publication-title: Iran. J. Fish. Sci.
– volume: 61
  start-page: 25
  year: 2017
  ident: ref_48
  article-title: A marine bio-functional lipid, fucoxanthinol, attenuates human colorectal cancer stem-like cell tumorigenicity and sphere formation
  publication-title: J. Clin. Biochem. Nutr.
  doi: 10.3164/jcbn.16-112
– volume: 80
  start-page: 209
  year: 2019
  ident: ref_76
  article-title: Protective role of fucoxanthin in diethylnitrosamine-induced hepatocarcinogenesis in experimental adult rats
  publication-title: Drug Dev. Res.
  doi: 10.1002/ddr.21451
– volume: 16
  start-page: 277
  year: 2015
  ident: ref_81
  article-title: Ultraviolet Keratitis: From the Pathophysiological Basis to Prevention and Clinical Management
  publication-title: High Alt. Med. Biol.
  doi: 10.1089/ham.2015.0109
– volume: 55
  start-page: 304
  year: 2008
  ident: ref_108
  article-title: Safety evaluation of fucoxanthin purified from Undaria pinnatifida
  publication-title: Nippon Shokuhin Kagaku Kogaku Kaishi
  doi: 10.3136/nskkk.55.304
– volume: 8
  start-page: 1381
  year: 2013
  ident: ref_28
  article-title: Anticholinesterase and antioxidant activities of fucoxanthin purified from the microalga Phaeodactylum tricornutum
  publication-title: Nat. Prod. Commun.
– volume: 528
  start-page: 305
  year: 2020
  ident: ref_37
  article-title: Fucoxanthin inhibits hepatic oxidative stress, inflammation, and fibrosis in diet-induced nonalcoholic steatohepatitis model mice
  publication-title: Biochem. Biophys. Res. Commun.
  doi: 10.1016/j.bbrc.2020.05.050
– volume: 11
  start-page: 3361
  year: 2020
  ident: ref_36
  article-title: Fucoxanthin alleviates palmitate-induced inflammation in RAW 264.7 cells through improving lipid metabolism and attenuating mitochondrial dysfunction
  publication-title: Food Funct.
  doi: 10.1039/D0FO00442A
– volume: 48
  start-page: 515
  year: 2018
  ident: ref_66
  article-title: Fucoxanthin ameliorates hyperglycemia, hyperlipidemia and insulin resistance in diabetic mice partially through IRS-1/PI3K/Akt and AMPK pathways
  publication-title: J. Funct. Foods
  doi: 10.1016/j.jff.2018.07.048
– volume: 95
  start-page: 835
  year: 2018
  ident: ref_30
  article-title: Isolation of Fucoxanthin from Brown Algae and Its Antioxidant Activity: In Vitro and 5% Fish Oil-In-Water Emulsion
  publication-title: JAOCS J. Am. Oil Chem. Soc.
  doi: 10.1002/aocs.12092
– volume: 495
  start-page: 197
  year: 2018
  ident: ref_16
  article-title: Fucoxanthin attenuates fatty acid-induced lipid accumulation in FL83B hepatocytes through regulated Sirt1/AMPK signaling pathway
  publication-title: Biochem. Biophys. Res. Commun.
  doi: 10.1016/j.bbrc.2017.11.022
– ident: ref_106
  doi: 10.3390/md18110557
– volume: 40
  start-page: 6799
  year: 2020
  ident: ref_52
  article-title: Anti-cancer effects of fucoxanthin on human glioblastoma cell line
  publication-title: Anticancer Res.
  doi: 10.21873/anticanres.14703
– ident: ref_83
  doi: 10.20944/preprints202005.0342.v1
– volume: 38
  start-page: 229
  year: 2019
  ident: ref_32
  article-title: Assessment of the Therapeutic Effects of Fucoxanthin by Attenuating Inflammation in Ovalbumin-Induced Asthma in an Experimental Animal Model
  publication-title: J. Environ. Pathol. Toxicol. Oncol.
  doi: 10.1615/JEnvironPatholToxicolOncol.2019030154
– volume: 8
  start-page: 349
  year: 2021
  ident: ref_40
  article-title: Fucoxanthin-rich fraction from Sargassum fusiformis alleviates particulate matter-induced inflammation in vitro and in vivo
  publication-title: Toxicol. Rep.
  doi: 10.1016/j.toxrep.2021.02.005
– volume: 8
  start-page: 239
  year: 2019
  ident: ref_26
  article-title: Fucoxanthin—An Antibacterial Carotenoid
  publication-title: Antioxidants
  doi: 10.3390/antiox8080239
– ident: ref_24
  doi: 10.3390/md16100378
– volume: 54
  start-page: 102187
  year: 2021
  ident: ref_63
  article-title: Polysaccharide (laminaran and fucoidan), fucoxanthin and lipids as functional components from brown algae (Padina tetrastromatica) modulates adipogenesis and thermogenesis in diet-induced obesity in C57BL6 mice
  publication-title: Algal. Res.
  doi: 10.1016/j.algal.2021.102187
– ident: ref_7
  doi: 10.3390/antiox8060183
– volume: 70
  start-page: 151
  year: 2019
  ident: ref_74
  article-title: Burden of liver diseases in the world
  publication-title: J. Hepatol.
  doi: 10.1016/j.jhep.2018.09.014
– volume: 34
  start-page: 1791
  year: 2020
  ident: ref_10
  article-title: Anti-inflammatory effect of fucoxanthin on dextran sulfate sodium-induced colitis in mice
  publication-title: Nat. Prod. Res.
  doi: 10.1080/14786419.2018.1528593
– volume: 7
  start-page: 246
  year: 2017
  ident: ref_15
  article-title: Seaweed fucoxanthin supplementation improves obesity parameters in mild obese Japanese subjects
  publication-title: Funct. Foods Health Dis.
  doi: 10.31989/ffhd.v7i4.333
– volume: 913
  start-page: 174629
  year: 2021
  ident: ref_67
  article-title: Fucoxanthin regulates Nrf2 signaling to decrease oxidative stress and improves renal fibrosis depending on Sirt1 in HG-induced GMCs and STZ-induced diabetic rats
  publication-title: Eur. J. Pharmacol.
  doi: 10.1016/j.ejphar.2021.174629
– volume: 36
  start-page: 195
  year: 2017
  ident: ref_109
  article-title: Fucoxanthin in the management of obesity and its related disorders
  publication-title: J. Funct. Foods
  doi: 10.1016/j.jff.2017.07.009
– volume: 68
  start-page: 5118
  year: 2020
  ident: ref_17
  article-title: Modulation of Gut Microbiota by Fucoxanthin during Alleviation of Obesity in High-Fat Diet-Fed Mice
  publication-title: J. Agric. Food Chem.
  doi: 10.1021/acs.jafc.0c01467
– volume: 59
  start-page: 24
  year: 2018
  ident: ref_13
  article-title: Cytotoxic activity of fucoxanthin, alone and in combination with the cancer drugs imatinib and doxorubicin, in CML cell lines
  publication-title: Environ. Toxicol. Pharmacol.
  doi: 10.1016/j.etap.2018.02.006
– volume: 34
  start-page: 431
  year: 2019
  ident: ref_41
  article-title: Fucoxanthin prevents lipopolysaccharide-induced depressive-like behavior in mice via AMPK- NF-κB pathway
  publication-title: Metab. Brain Dis.
  doi: 10.1007/s11011-018-0368-2
– ident: ref_110
  doi: 10.3390/foods9081113
– volume: 23
  start-page: 2219
  year: 2019
  ident: ref_12
  article-title: Fucoxanthin inhibits tumour-related lymphangiogenesis and growth of breast cancer
  publication-title: J. Cell. Mol. Med.
  doi: 10.1111/jcmm.14151
– ident: ref_21
  doi: 10.1016/j.jff.2019.103542
– volume: 65
  start-page: 405
  year: 2021
  ident: ref_46
  article-title: Identification of Paracentrone in Fucoxanthin-Fed Mice and Anti-Inflammatory Effect against Lipopolysaccharide-Stimulated Macrophages and Adipocytes
  publication-title: Mol. Nutr. Food Res.
  doi: 10.1002/mnfr.202000405
– ident: ref_57
  doi: 10.3390/ijms222413620
– volume: 4
  start-page: 81
  year: 2018
  ident: ref_51
  article-title: In vitro investigating of anticancer activity of focuxanthin from marine brown seaweed species
  publication-title: Glob. J. Environ. Sci. Manag.
– ident: ref_43
  doi: 10.3390/cells10061311
– volume: 16
  start-page: 242
  year: 2020
  ident: ref_22
  article-title: Protective effect of fucoxanthin on ovariectomy-induced osteoporosis in rats
  publication-title: Pharmacogn. Mag.
– volume: 41
  start-page: 1299
  year: 2021
  ident: ref_49
  article-title: Fucoxanthin prevents colorectal cancer development in dextran sodium sulfate-treated ApcMin/+ mice
  publication-title: Anticancer Res.
  doi: 10.21873/anticanres.14887
SSID ssj0035894
Score 2.5493443
SecondaryResourceType review_article
Snippet Fucoxanthin, belonging to the xanthophyll class of carotenoids, is a natural antioxidant pigment of marine algae, including brown macroalgae and diatoms. It...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 279
SubjectTerms Algae
Anticancer properties
Antioxidants
Antitumor agents
bioactivities
Biocompatibility
Cancer
Carotenoids
Chemical kinetics
Diabetes mellitus
Diatoms
Disease prevention
Fucoxanthin
Functional foods & nutraceuticals
Heart diseases
Herbal medicine
Human subjects
Humans
in vitro
in vivo
Inflammation
Marine microorganisms
Metabolism
Metabolites
Microorganisms
Molecular modelling
Neoplasms
Nervous system
Obesity
Oxidative stress
Pharmaceuticals
Pharmacokinetics
Pharmacology
Review
safety and toxicity
Scientific papers
Seaweed - chemistry
Skin diseases
Toxicity
Tumors
Xanthophylls
Xanthophylls - chemistry
Xanthophylls - pharmacology
Xanthophylls - therapeutic use
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3di9QwEA9yT76I31ZPiSgHwhXTNk03vq0fyymcHHgL92SZfHkHR3q4u-L998403e6uHPjiazOUdGYyM78m8wtjr0XQxuumyDFbSQQoMMnB2zqvLUZDEJUFRw3Ox1_V0Vx-OavPtq76ojNhiR44Ke6tq5yxurRQO4dQQhilnPVBCxDS1xAo-mLOW4OpFIOreqJlIiOtENQjuKefJ4jA9E766Vn6byot_z4huZVyZnfZnaFW5NM0x3vslo_32cFJIpu-PuSnm96pxSE_4CcbGurrB-z7lH8baZp52gPgXeTHQA1_fHr5A3z-ER3wl3d8trLdb1Ty-UV8x6eRz6_oTwDvwvZLyZ78c1wQnl88ZPPZp9MPR_lwm0JuZVMuc4PAwmqvfAPOAqLiQvqAKRJMJVyjjajBiKAc7W9NRAjGGIA6NMYXFqwS1SO2F7vonzAuTdMXFwasl4h_tLSyMF5JKG1RNC5jb9ZKbu1ANU43Xly2CDnIIO3GIBl7NcpeJYKNG6Xek61GCSLF7h-gq7SDq7T_cpWM7a8t3Q4rddGWCmMeakOqjL0ch3GN0cYJRN-tehniwcdKJ2OPk2OMM6mwgMQiWGSs2XGZnanujsSL857HW1OWUpOn_-PbnrHbJTVmCJmX5T7bW_5c-edYLi3Ni35l_AHLORjy
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3da9RAEF-0vvgitn6l1rKiFIQubpLN5tYXOT-OKlQK9uCeDLMfaQslOZs7af97Z5JcrifF1-wQlp3ZnfnN7vyGsbeyNDaYPBborRQCFBgJCC4TmcPTEGTqwFOB8_EPfTRV32fZrE-4Nf2zytWZ2B7UvnaUI3-faLRNxHJKf5z_FtQ1im5X-xYa99kDoi6jJ135bABcaTYyqqMkTRHaI8SnFAriMLPhhFqu_rsCzH_fSd5yPJPH7FEfMfJxp-Jtdi9UO-zgpKOcvjnkp-sKquaQH_CTNRn1zRP2a8x_DmTNvLsJ4HXFj4HK_vj48gyC-IJm-Cd4Plm6-hqX-vyi-sDHFZ_OKR_A6_L2T0mr_FvVEKpvnrLp5Ovp5yPR91QQTuXJQliEF84EHXLwDnA9YxVKdJRgU-lzY2UGVpba0y3XSJaltRYgK3MbYgdOy_QZ26rqKrxgXNm8DTEsuKAQBRnlVGyDVpC4OM59xN6tFrlwPeE49b24LBB4kEKKtUIi9maQnXc0G3dKfSJdDRJEjd1-qK_Oin6nFT711pnEQeY9Yk9ptUYFlkaCVCGDMmJ7K00X_X5tirV1Rez1MIw7ja5PoAr1spUhNnyMdyL2vDOMYSYphpEYCsuI5RsmszHVzZHq4rxl8zbkq_Ro9__TeskeJlR4IZVIkj22tbhahlcYDi3sfmvzfwHpuQ6V
  priority: 102
  providerName: ProQuest
Title A Systematic Review on Marine Algae-Derived Fucoxanthin: An Update of Pharmacological Insights
URI https://www.ncbi.nlm.nih.gov/pubmed/35621930
https://www.proquest.com/docview/2670346946
https://www.proquest.com/docview/2671275521
https://pubmed.ncbi.nlm.nih.gov/PMC9146768
https://doaj.org/article/d3dbc92ca5dd4480b66dcef90a04e5af
Volume 20
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Za9tAEB5yvPSlND3VpmZLS6AQlZW02rUKpThtTFpwMG0MfqrYMwkYKfUR4n_fWUmW4-CHvmpHBzM7O_PtaL8B-EBdpmwmohCjFUOAIruhtDoNU42roaSJlsYfcB6c87MR-zlOxzuw6t_ZKHC2Fdr5flKj6eTT3d_lV3T4Lx5xImRH6O63RhBfZbuwjxFJeAcdsLaakKTdqiFixDmuORiAa5rSB_duBKaKv39b0vnw38l7waj_BB43WSTp1WY_gB1bPIWjYU1DvTwmF-tTVbNjckSGa4Lq5TP40yO_WwJnUlcHSFmQgfRHAUlvcilt-B2n5q01pL_Q5R2q_-q6-Ex6BRnd-D0CUrr7D_WWJj-KmUf6s-cw6p9efDsLmz4LoWYinocKIYfOLLdCGi0RL0fMOgyeUiXUiEzRVCrquPGVry51TiklZeqEspGWmtPkBewVZWFfAWFKVGmHktoyREYZ0yxSljMZ6ygSJoCPKyXnuiEh970wJjmCEW-QfG2QAN63sjc19cZWqRNvq1bC02VXF8rpZd54X24So3QWa5kag3iUKs7RgC6jkjKbShfA4crS-WoK5jHH1RC1wXgA79ph9D5fUpGFLReVjGfIxxwogJf1xGi_JMHUEtNjGoDYmDIbn7o5UlxfVQzfmY9fvPv6P977Bh7F_kQGZWEcH8LefLqwbzFPmqsO7Iqx6MD-yen58Fen2m3oVI7xD0XGF6g
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEB6V9AAXxBtDgUVAJaRaXdtrO4uEUEobJbSJIkiknjD7clup2KFJgPwpfiOzfqVBFbdevaPVyvOe3fkG4DVNuTQ89lz0VgwTFNF2hVGhGyq0hoIGSmjb4DwYRr0J-3QcHm_An7oXxj6rrG1iYah1rmyNfNePUDYxl2PRh-kP106Nsrer9QiNUiwOzfIXpmyz9_195O8b3-8ejD_23GqqgKtY7M9diQG24iYysdBK4I4eMym6CiEDqmMuaSgkTSNt73naNE2llEKEaSyNp4SKaID73oBNFmAq04LNvYPh6HNt-4OwzVkJghoEnO5-17Zog5kfX3N7xXSAq0Laf19mXnJ13Ttwu4pRSacUqruwYbJ7sD0qQa6XO2S86tma7ZBtMlrBXy_vw9cO-dLAQ5Py7oHkGRkI22hIOucnwrj7KPg_jSbdhcp_I3NPz7J3pJORydRWIEieXt7UyhHpZzNbR5g9gMm1_O-H0MryzDwGwmRcBDVSKMMw7-JMMU-aiAlfeV6sHXhb_-REVRDndtLGeYKpjmVIsmKIA68a2mkJ7HEl1Z7lVUNhwbiLD_nFSVLpdqIDLRX3lQi1xmyXyihCBqacCspMKFIHtmpOJ5WFmCUreXbgZbOMum0vbERm8kVBY_H3McJy4FEpGM1JAgxcMfimDsRrIrN21PWV7Oy0wA_n1jtG7Sf_P9YLuNkbD46So_7w8Cnc8m3bB2Wu729Ba36xMM8wGJvL55UGEPh23Ur3F20uUC4
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1baxNBFD7UCuKLeHe16ohaELpkdnd2NiOIRGNorC0BG8hT17ltW6i7sUnU_DV_nWf2lkaKb33dOQzDnvuZOd8BeEUzoaxIAh-9FcMERXZ9aXXsxxqtoaSRlsY1OO8f8N0x-zyJJxvwp-mFcc8qG5tYGmpTaFcj74QcZRNzOcY7Wf0sYtQfvJ_-8N0EKXfT2ozTqERkzy5_Yfo2ezfsI69fh-Hg0-HHXb-eMOBrloRzX2GwrYXlNpFGS9w9YDZDtyFVRE0iFI2lohk37s6nS7NMKSVlnCXKBlpqTiPc9xpcT6I4cDqWTNpkL4q7glVwqFEkaOe7ceUbzAHFmgMs5wRcFtz--0bzgtMb3IZbdbRKepV43YENm9-F7VEFd73cIYer7q3ZDtkmoxUQ9vIeHPXI1xYomlS3EKTIyb50LYekd3Ysrd9HFfhpDRksdPEb2Xxymr8lvZyMp64WQYrs4qZOosgwn7mKwuw-jK_kbz-AzbzI7SMgTCVleKOktgwzMME0C5TlTIY6CBLjwZvmJ6e6Bjt3MzfOUkx6HEPSFUM8eNnSTiuIj0upPjhetRQOlrv8UJwfp7WWpyYySotQy9gYzHup4hwZmAkqKbOxzDzYajid1rZilq4k24MX7TJqubu6kbktFiWNQ-LHWMuDh5VgtCeJMITFMJx6kKyJzNpR11fy05MSSVw4P8m7j_9_rOdwA1Ut_TI82HsCN0PX_0GZH4ZbsDk_X9inGJXN1bNS_Al8u2p9-wvwglL-
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+Systematic+Review+on+Marine+Algae-Derived+Fucoxanthin%3A+An+Update+of+Pharmacological+Insights&rft.jtitle=Marine+drugs&rft.au=Mohibbullah%2C+Md&rft.au=Haque%2C+Md+Nazmul&rft.au=Sohag%2C+Abdullah+Al+Mamun&rft.au=Hossain%2C+Md+Tahmeed&rft.date=2022-04-22&rft.issn=1660-3397&rft.eissn=1660-3397&rft.volume=20&rft.issue=5&rft_id=info:doi/10.3390%2Fmd20050279&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1660-3397&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1660-3397&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1660-3397&client=summon